Investor Relations

Financial Releases

Date Title and Summary Additional Formats
Toggle Summary Intersect ENT Reports Fourth Quarter and Year 2015 Results
Full Year Revenue Increased 60% Year Over Year; Gross Margin at 80% MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the fourth
View HTML
Toggle Summary Intersect ENT to Report Fourth Quarter and Year 2015 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its fourth quarter and year 2015 on February 23, 2016 .
View HTML
Toggle Summary Intersect ENT to Present at LEERINK Partners Global Healthcare Conference
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will present an overview of the company's business at the 5 th Annual LEERINK Partners Global Healthcare Conference . The presentation at the LEERINK Partners conference is scheduled for 2:40pm
View HTML
Toggle Summary Intersect ENT Reports Preliminary Q4 and Year 2015 Revenue
Full Year Revenue Grew 60% Year Over Year MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT , Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported preliminary revenue for the fourth quarter and year
View HTML
Toggle Summary Intersect ENT to Present at the 34th Annual J.P. Morgan Healthcare Conference
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq: XENT ), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced that management will present an overview of the company's business, including certain preliminary 2015
View HTML
Toggle Summary Intersect ENT to Present at Piper Jaffray Conference
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will present an overview of the company's business at the 27 th Annual Piper Jaffray Healthcare Conference . The presentation at the Piper Jaffray conference is scheduled for 9:30 a.m.
View HTML
Toggle Summary Intersect ENT Reports Third Quarter 2015 Results
Revenue Increased 56% Year over Year and Gross Margin at 80% MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT , Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the third quarter
View HTML
Toggle Summary Intersect ENT to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will present an overview of the company's business at the 9 th Annual Canaccord Genuity Medical Technology and Diagnostics Forum . The presentation at the Canaccord Genuity forum is scheduled
View HTML
Toggle Summary Intersect ENT to Announce Third Quarter Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release its third quarter financial results on November 4, 2015 .
View HTML
Toggle Summary Intersect ENT Reports Second Quarter 2015 Results
Revenue Increased 77% Year Over Year to $15.2 Million and Gross Margins Rise to 81% MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT , Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for
View HTML